These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 37753284)

  • 1. α
    Winther SV; Landt EM; Nordestgaard BG; Seersholm N; Dahl M
    ERJ Open Res; 2023 Sep; 9(5):. PubMed ID: 37753284
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Severe α
    Winther SV; Ahmed D; Al-Shuweli S; Landt EM; Nordestgaard BG; Seersholm N; Dahl M
    Respir Res; 2022 Mar; 23(1):55. PubMed ID: 35264159
    [TBL] [Abstract][Full Text] [Related]  

  • 3. α
    Riis J; Nordestgaard BG; Afzal S
    J Thromb Haemost; 2022 Jan; 20(1):115-125. PubMed ID: 34662507
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Change in lung function and morbidity from chronic obstructive pulmonary disease in alpha1-antitrypsin MZ heterozygotes: A longitudinal study of the general population.
    Dahl M; Tybjaerg-Hansen A; Lange P; Vestbo J; Nordestgaard BG
    Ann Intern Med; 2002 Feb; 136(4):270-9. PubMed ID: 11848724
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fibrinogen and α1-antitrypsin in COPD exacerbations.
    Ingebrigtsen TS; Marott JL; Rode L; Vestbo J; Lange P; Nordestgaard BG
    Thorax; 2015 Nov; 70(11):1014-21. PubMed ID: 26304913
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intravenous augmentation treatment and lung density in severe α1 antitrypsin deficiency (RAPID): a randomised, double-blind, placebo-controlled trial.
    Chapman KR; Burdon JG; Piitulainen E; Sandhaus RA; Seersholm N; Stocks JM; Stoel BC; Huang L; Yao Z; Edelman JM; McElvaney NG;
    Lancet; 2015 Jul; 386(9991):360-8. PubMed ID: 26026936
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of oxidative stress-related biomarkers in heart failure: galectin 3, α1-antitrypsin and LOX-1: new therapeutic perspective?
    Lubrano V; Balzan S
    Mol Cell Biochem; 2020 Jan; 464(1-2):143-152. PubMed ID: 31782085
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blood pressure, risk of ischemic cerebrovascular and ischemic heart disease, and longevity in alpha(1)-antitrypsin deficiency: the Copenhagen City Heart Study.
    Dahl M; Tybjaerg-Hansen A; Sillesen H; Jensen G; Steffensen R; Nordestgaard BG
    Circulation; 2003 Feb; 107(5):747-52. PubMed ID: 12578879
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic and biochemical markers of obstructive lung disease in the general population.
    Dahl M
    Clin Respir J; 2009 Apr; 3(2):121-2. PubMed ID: 20298391
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decreased Risk of Ischemic Heart Disease in Individuals with Severe Alpha 1-Antitrypsin Deficiency (PiZZ) in Comparison with the General Population.
    Tanash H; Ekström M; Basil N; Rönmark E; Lindberg A; Piitulainen E
    Int J Chron Obstruct Pulmon Dis; 2020; 15():1245-1252. PubMed ID: 32606637
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mortality and morbidity in patients with osteogenesis imperfecta in Denmark.
    Folkestad L
    Dan Med J; 2018 Apr; 65(4):. PubMed ID: 29619932
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Altered elastase-alpha1-antitrypsin balance in the blood of patients with chronic venous disease.
    Budzyn-Napierala M; Iskra M; Krasinski Z; Turkiewicz W; Gryszczynska B; Kasprzak M; Urbanek T
    Phlebology; 2016 Mar; 31(2):125-32. PubMed ID: 25632064
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fibromuscular dysplasia of the internal carotid artery associated with alpha1-antitrypsin deficiency.
    Schievink WI; Meyer FB; Parisi JE; Wijdicks EF
    Neurosurgery; 1998 Aug; 43(2):229-33; discussion 233-4. PubMed ID: 9696074
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Registry-based cohort study of alpha-1 antitrypsin deficiency prevalence, incidence and mortality in Denmark 2000-2018.
    Acquavella J; Vágó E; Sorensen HT; Horváth-Puhó E; Hess GP
    BMJ Open Respir Res; 2022 Dec; 9(1):. PubMed ID: 36549785
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term treatment of alpha1-antitrypsin deficiency-related pulmonary emphysema with human alpha1-antitrypsin. Wissenschaftliche Arbeitsgemeinschaft zur Therapie von Lungenerkrankungen (WATL)-alpha1-AT-study group.
    Wencker M; Banik N; Buhl R; Seidel R; Konietzko N
    Eur Respir J; 1998 Feb; 11(2):428-33. PubMed ID: 9551749
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cause-specific mortality in individuals with severe alpha 1-antitrypsin deficiency in comparison with the general population in Sweden.
    Tanash HA; Ekström M; Wagner P; Piitulainen E
    Int J Chron Obstruct Pulmon Dis; 2016; 11():1663-9. PubMed ID: 27555756
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does alpha1-antitrypsin augmentation therapy slow the annual decline in FEV1 in patients with severe hereditary alpha1-antitrypsin deficiency? Wissenschaftliche Arbeitsgemeinschaft zur Therapie von Lungenerkrankungen (WATL) alpha1-AT study group.
    Seersholm N; Wencker M; Banik N; Viskum K; Dirksen A; Kok-Jensen A; Konietzko N
    Eur Respir J; 1997 Oct; 10(10):2260-3. PubMed ID: 9387950
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alpha1-antitrypsin deficiency.
    Stoller JK; Aboussouan LS
    Lancet; 2005 Jun 25-Jul 1; 365(9478):2225-36. PubMed ID: 15978931
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Natural history of abdominal aortic aneurysm with and without coexisting chronic obstructive pulmonary disease.
    Lindholt JS; Heickendorff L; Antonsen S; Fasting H; Henneberg EW
    J Vasc Surg; 1998 Aug; 28(2):226-33. PubMed ID: 9719317
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term risk of adverse cardiovascular outcomes associated with cutaneous lupus erythematosus: a nationwide cohort study.
    Shams-Eldin AN; Yafasova A; Faurschou M; Schou M; Sun G; Gislason GH; Torp-Pedersen C; Fosbøl EL; Køber L; Butt JH
    Clin Rheumatol; 2022 Nov; 41(11):3525-3536. PubMed ID: 35907102
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.